XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Unaudited Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Income Statement [Abstract]    
Net revenue [1] $ 164,586 $ 180,908 [2]
Cost of revenue 116,349 120,526
Gross profit 48,237 60,382
Operating expenses:    
Research and development 20,227 22,134
Sales and marketing 30,529 33,879
General and administrative 18,067 16,236
Other operating expenses, net 1,062 108
Total operating expenses 69,885 72,357
Loss from operations (21,648) (11,975)
Other income, net [3] 2,850 1,406 [2]
Loss before income taxes (18,798) (10,569) [2]
Benefit from income taxes (148) (857)
Net loss $ (18,650) $ (9,712)
Net loss per share    
Basic $ (0.63) $ (0.33)
Diluted $ (0.63) $ (0.33)
Weighted average shares used to compute net loss per share:    
Basic 29,395 29,040
Diluted 29,395 29,040
[1] No individual foreign country represented more than 10% of the Companys total net revenue in the periods presented.
[2]

* Financial information for each reportable segment were recast to conform to the current reportable segment structure.

[3] Amounts included gain/(loss), net from derivatives not designated as hedging instruments of $1.5 million and $(0.2) million, for the three months ended March 31, 2024 and April 2, 2023, respectively.